EPCT-04. RESULTS OF A PHASE 1 STUDY OF THE ONCOLYTIC ADENOVIRUS DNX-2401 WITH RADIOTHERAPY FOR NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)
Marc García-Moure(Navarre Institute of Health Research), Sonia Tejada(Universidad de Navarra), Miguel García-Ariza(Hospital de Cruces), Marta M. Alonso(BioCruces Health research Institute), Jaime Gállego Pérez‐Larraya(Navarre Institute of Health Research), Blanca López‐Ibor, Frederick F. Lang(The University of Texas MD Anderson Cancer Center), Chris Jones(North Carolina State University), Juàn Fueyo(The University of Texas MD Anderson Cancer Center), Itziar Astigarraga, Ricardo Díez-Valle(Navarre Institute of Health Research), Marisol González-Huarriz(Navarre Institute of Health Research), María Villalba(Navarre Institute of Health Research), Candelaria Gomez‐Manzano(The University of Texas MD Anderson Cancer Center), Esther Hulleman(Amsterdam UMC Location VUmc), Alan Mackay(Institute of Cancer Research), Jasper van der Lugt(Princess Máxima Center), Jessica Dobbs(Janssen (United States)), Carlos de Andrea(Navarre Institute of Health Research), Ana Patiño‐García(Navarre Institute of Health Research)
Cited by 1
Related Papers
Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma
|Cancer Cell|2017|1.3k
BRCA1 Basal-like Breast Cancers Originate from Luminal Epithelial Progenitors and Not from Basal Stem Cells
|Cell stem cell|2010|814
<i>FGFR1</i> Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer
|Cancer Research|2010|740
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
|Nature Medicine|2015|711